Pancreaticobiliary Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2014-05-19
Clinical Trial Update: BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer [Phase 1]
Phase 1 trial of lapatinib with gemcitabine in metastatic pancreaticobiliary cancer was terminated; results posted in 2014.